[HTML][HTML] Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
RC Smallridge, LA Marlow… - Endocrine-related …, 2009 - erc.bioscientifica.com
Anaplastic thyroid cancer (ATC) is a rare malignancy. While external beam radiation therapy
has improved locoregional control, the median survival of∼ 4 months has not changed in …
has improved locoregional control, the median survival of∼ 4 months has not changed in …
Aggressive differentiated thyroid cancer
N Janjua, VB Wreesmann - European Journal of Surgical Oncology, 2018 - Elsevier
Differentiated thyroid cancer is characteristically associated with an innocuous clinical
course, but a minority of cases may manifest surprisingly aggressive behaviour. Such …
course, but a minority of cases may manifest surprisingly aggressive behaviour. Such …
[HTML][HTML] Epigenetics modifications and therapeutic prospects in human thyroid cancer
MG Catalano, N Fortunati, G Boccuzzi - Frontiers in Endocrinology, 2012 - frontiersin.org
At present no successful treatment is available for advanced thyroid cancer, which
comprises poorly differentiated, anaplastic, and metastatic or recurrent differentiated thyroid …
comprises poorly differentiated, anaplastic, and metastatic or recurrent differentiated thyroid …
Surgical management of well-differentiated thyroid cancer: state of the art
J Suliburk, L Delbridge - Surgical Clinics, 2009 - surgical.theclinics.com
When the subject of the extent surgery for well-differentiated thyroid cancer (WDTC) was last
reviewed in Surgical Clinics of North America, Dackiw and Zeiger noted that it continued to …
reviewed in Surgical Clinics of North America, Dackiw and Zeiger noted that it continued to …
Emerging molecular therapies of advanced thyroid cancer
MG Catalano, R Poli, M Pugliese, N Fortunati… - Molecular aspects of …, 2010 - Elsevier
Advanced thyroid cancer refers to thyroid tumors which are resistant to conventional
therapies and do not respond to radioiodine and comprises metastatic or recurrent …
therapies and do not respond to radioiodine and comprises metastatic or recurrent …
Multiple mutations detected preoperatively may predict aggressive behavior of papillary thyroid cancer and guide management—a case report
Background: Multiple gene mutations in thyroid nodules are rare. The presence of several
oncogenic mutations could be associated with aggressive biological behavior of tumors …
oncogenic mutations could be associated with aggressive biological behavior of tumors …
[PDF][PDF] 甲状腺癌分子发病机制研究进展
阿勒哈， 孟庆彬， 于健春， 康维明… - 中国医学 …, 2013 - journal13.magtechjournal.com
甲状腺癌是常见的内分泌肿瘤之一, 不同组织学类型的甲状腺癌生物学行为及预后差异很大,
目前对于高侵袭性甲状腺癌传统治疗手段疗效仍然非常有限. 随着对甲状腺癌分子发病机制的 …
目前对于高侵袭性甲状腺癌传统治疗手段疗效仍然非常有限. 随着对甲状腺癌分子发病机制的 …
分化型甲状腺癌的治疗策略(续一)
杨春明 - 中华内分泌外科杂志, 2011 - cqvip.com
分化型甲状腺癌的治疗策略(续一)-[维普官方网站]-www.cqvip.com-维普网 我的维普 购物车
充值 客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 会议平台 …
充值 客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 会议平台 …
甲状腺乳头状癌组织中炎性因子的表达及其临床意义
孙勤暖， 李冬梅， 于慧玲， 马洪喜 - 吉林大学学报(医学版), 2015 - xuebao.jlu.edu.cn
目的: 探讨甲状腺乳头状癌组织中炎性因子的表达及其与甲状腺乳头状癌临床病理特征的关系,
为指导临床用药和判断预后奠定实验基础. 方法: 选取穿刺确诊为甲状腺乳头状癌的74 …
为指导临床用药和判断预后奠定实验基础. 方法: 选取穿刺确诊为甲状腺乳头状癌的74 …
[PDF][PDF] Importance of epigenetic changes in the thyroid cancer incidence and their therapeutic applications
Thyroid cancer, the most common endocrine malignancy worldwide, originates from
follicular epithelial cells. It is classified as a well-differentiated thyroid carcinoma (WDTC) …
follicular epithelial cells. It is classified as a well-differentiated thyroid carcinoma (WDTC) …